title: Expression of macrophage p120 depends on early protein synthesis.
abstract: We have previously identified a group of early proteins preceding the expression of a 120-kDa protein (p120) which coincides with tumoricidal activation in peritoneal macrophages. In the present report, we have asked whether the in vitro induction of new or enhanced expression of p120 depends on early protein synthesis and RNA synthesis during the treatment period. Expression of p120 was sensitive to pretreatment of the macrophages with either actinomycin D or cycloheximide, indicating that both active protein synthesis and RNA synthesis were required. When poly-adenylated RNA isolated from various macrophage populations was translated in a rabbit reticulocyte in vitro translation system, only mRNA isolated from cells which express p120 was able to direct synthesis of a 120-kDa polypeptide. This product showed identical mobility to p120 induced in intact activated macrophages radiolabeled with [35S]methionine. The presence of translatable p120 mRNA was dependent upon treatment of thioglycollate-elicited macrophages with both IFN-gamma plus LPS at low doses, as is expression of p120 in intact cells. Accumulation of translatable p120 mRNA was blocked by treatment with cycloheximide, indicating that active protein synthesis was required during the induction period. These results suggest that the presence of specific translatable mRNA encoding the p120 polypeptide is dependent upon the expression of early macrophage gene products.
authors.affiliation: Biomedical Division, Samuel Roberts Noble Foundation, Inc., Ardmore, OK 73402.
authors.forename: P A
authors.initials: PA
authors.lastname: Johnston
authors.forename: T J
authors.initials: TJ
authors.lastname: Koerner
authors.forename: M M
authors.initials: MM
authors.lastname: Jansen
authors.forename: T A
authors.initials: TA
authors.lastname: Hamilton
mesh_terms: D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology; D003603:Cytotoxins / Q000096:biosynthesis*; D005786:Gene Expression Regulation; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008262:Macrophage Activation; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D014176:Protein Biosynthesis; D011506:Proteins; D012333:RNA, Messenger / Q000096:biosynthesis; D013864:Thioglycolates / Q000494:pharmacology
chemical_list: C051682:120-kDa macrophage tumoricidal protein, mouse; D003603:Cytotoxins; D008070:Lipopolysaccharides; D011506:Proteins; D012333:RNA, Messenger; D013864:Thioglycolates; D007371:Interferon-gamma; D003513:Cycloheximide